Antimitotic Agents: all 5,052 studies that test it
Page 6 of 51. Open to participants first (616), then studies with results posted, then the rest; newest registration first within each.
- Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or ThoraxRecruitingNCT05092373Phase 1
- Adjuvant Chemotherapy for High-risk Postenucleation RetinoblastomaRecruitingNCT05080010Phase 3
- Cyclin dEpendent Kinase in tRiple nEGatIVe brEast canceR - a "Window of Opportunity" StudyNot yet recruitingNCT05067530Phase 2
- Using Genetic Profile to Determine the Treatment for Patients With Ovarian Cancer Who Previously Received a PARP-inhibitorRecruitingNCT05065021Phase 2
- Investigator-initiated Clinical Trial of MIKE-1RecruitingNCT05064618Phase 1/2
- Vinblastine for Leukoreduction in Newly Diagnosed AML and HyperleukocytosisRecruitingNCT05062278Phase 2
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid TumorsRecruitingNCT05039801Phase 1
- Albumin-bound Paclitaxel Combined With Gemcitabine First-line Inoperable Pancreatic CancerRecruitingNCT05035147Phase 4
- Immunotherapy With Chemotherapy and Chemoradiation for Advanced Squamous Cancer of Nasal Cavity / Paranasal Sinuses (I-NAPA)RecruitingNCT05027633Phase 2
- Testing the Safety and Efficacy of the Addition of a New Anti-cancer Drug, ZEN003694, to Chemotherapy Treatment (Cisplatin and Etoposide or Carboplatin and Paclitaxel) for Adult and Pediatric Patients (12-17 Years) With NUT CarcinomaRecruitingNCT05019716Phase 1/2
- Apatinib Combined with Albumin-Bound Paclitaxel for Treatment of Advanced Triple Negative Breast CancerRecruitingNCT05019690Phase 1/2
- Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant NeoplasmsRecruitingNCT05000892Phase 2
- Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction CancerRecruitingNCT04999332Phase 2
- Scalp Cooling in MBCRecruitingNCT04986579Phase 2
- Intraperitoneal Paclitaxel With XELOX in Gastric Cancer With Peritoneal MetastasisRecruitingNCT04943653Phase 1/2
- Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D)Not yet recruitingNCT04922008Phase 2
- Pyrotinib Versus Pertuzumab in Combination With Neoadjuvant Trastuzumab and Nab-Paclitaxel in HER2+ Early or Locally Advanced Breast CancerNot yet recruitingNCT04900311Phase 2
- Preoperative, Proton- Radiotherapy Combined With Chemotherapy for Borderline Resectable Pancreatic CancerRecruitingNCT04894643Not applicable
- ATEMPT 2.0: Adjuvant T-DM1 vs THRecruitingNCT04893109Phase 2
- An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)RecruitingNCT04876313Phase 2
- Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in GoutRecruitingNCT04875702Phase 4
- Penpulimab-based Combination Neoadjuvant/Adjuvant Therapy for Patients With Resectable Locally Advanced Non-small Cell Lung Cancer: a Phase II Clinical Study (ALTER-L043)Not yet recruitingNCT04846634Phase 2
- Docetaxel, Oxaliplatin and 5-FU for Gastric Cancer With Inoperable Malignant Bowel ObstructionRecruitingNCT04840264Phase 2
- Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer PatientsRecruitingNCT04836156Phase 1/2
- Neoadjuvant Camrelizumab in Combination With Cisplatin and Nab-paclitaxel in Resectable HNSCCRecruitingNCT04826679Phase 2
- Neoadjuvant Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant NeoplasmsNot yet recruitingNCT04825938Phase 2
- A Phase I Open-Label, Single-Arm, Dose-Escalation Clinical and Pharmacology Study of CCI-001 as Monotherapy and in Combination With Standard Chemotherapy in Patients With Recurrent and/or Metastatic Solid TumoursRecruitingNCT04823897Phase 1
- Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate CancerRecruitingNCT04812366Phase 2
- Comparative Study of Lobaplatin and Paclitaxel in Advanced Gastric Cancer Patients With D2 Surgery Combined With Hyperthermic Intraperitoneal ChemotherapyRecruitingNCT04808466Phase 2
- Pembrolizumab Plus Neoadjuvant Chemotherapy vs. Neoadjuvant Chemoradiotherapy for Locally Advanced ESCC (KEYSTONE-002)RecruitingNCT04807673Phase 3
- Neoadjuvant Toripalimab or Toripalimab in Combination With Carboplatin and Nab-paclitaxel in Untreated HNSCC (HNSCC-002)RecruitingNCT04807140Phase 2
- Apatinib Plus Camrelizumab Combined With Docetaxel and S1 in First-line Treatment for Metastatic Gastric CancerRecruitingNCT04781686Phase 2
- Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular RiskRecruitingNCT04774159Phase 3
- A Prospective Study for the Treatment of Children With Newly Diagnosed LCH Using a Cytarabine Contained ProtocolRecruitingNCT04773366Phase 3
- MicroRNA Profiles in Triple Negative Breast CancerRecruitingNCT04771871Phase 2
- Paclitaxel (Albumin-bound) Combined With Radiotherapy for the Treatment of Early Stage Nasopharyngeal CarcinomaNot yet recruitingNCT04766359Phase 3
- Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)RecruitingNCT04747912Phase 2
- Folfox+Irinotecan+Chemort In Esophageal CancerRecruitingNCT04656041Phase 2
- First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)RecruitingNCT04638790Phase 3
- Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract CancerRecruitingNCT04628767Phase 2/3
- FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcomaRecruitingNCT04625907Phase 1/2
- Phase II Study of the Use of Neoadjuvant Cabazitaxel With Hormonal Treatment in Patients Operable Prostate Cancer, Assess the Efficacy and Toxicity of Cabazitaxel, and Explore Potential Predictive and Prognostic Markers of Clinical OutcomeNot yet recruitingNCT04622761Phase 2
- NBTXR3, Chemotherapy, and Radiation Therapy for the Treatment of Esophageal CancerRecruitingNCT04615013Phase 1
- Pembrolizumab, Olaparib, Recurrent/Advanced Gastric and Gastro-esophageal Junction(GEJ) CancerRecruitingNCT04592211Phase 1/2
- Adaptive ctDNA-Based Personalization of Treatment During Consolidation Therapy in NSCLCRecruitingNCT04585490Phase 3
- Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue SarcomaRecruitingNCT04577014Phase 1/2
- Efficacy and Safety of Dose-dense Chemotherapy (ddEC-ddP) for Neoadjuvant Chemotherapy of HER2-negative Breast CancerRecruitingNCT04576143Phase 2/3
- GALLANT: Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab for Advanced SarcomaRecruitingNCT04535713Phase 2
- Phase III Study of Concurrent Radiotherapy in Elderly Patients With Esophageal Squamous Cell Carcinoma (ESO-Shanghai 15)RecruitingNCT04519905Not applicable
- A Trial of AMXI-5001 for Treatment in Patients With Advanced MalignanciesRecruitingNCT04503265Phase 1/2
- Induction Chemotherapy in Locally Advanced Hypopharyngeal Carcinoma: a Randomised Phase 3 TrialRecruitingNCT04502641Phase 3
- Anti-Inflammatory Treatment of Uremic Cardiomyopathy With ColchicineRecruitingNCT04500665Phase 2
- Pegaspargase-COEP Chemotherapy Combined With Radiotherapy for Extra-nodal NK/T Cell LymphomaRecruitingNCT04484506Phase 2
- TGF-β And PDL-1 Inhibition in Esophageal Squamous Cell Carcinoma Combined With Chemoradiation TheRapYRecruitingNCT04481256Not applicable
- Chemoradiotherapy Followed by Planned Surgery or by Surveillance and Surgery Only When Needed for Oesophageal CancerRecruitingNCT04460352Phase 3
- Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before SurgeryRecruitingNCT04452461Phase 2
- Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and PaclitaxelRecruitingNCT04449549Phase 2
- Efficacy of Acute Lymphoblastic Leukemia-Based Therapy in Treating Patients With Acute Leukemia of Ambiguous LineageRecruitingNCT04440267Phase 2
- The Efficacy of Adjuvant Chemotherapy in Locally Advanced Cervical CancerRecruitingNCT04409860Not applicable
- Randomised Evaluation of COVID-19 TherapyRecruitingNCT04381936Phase 3
- Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel ChemotherapiesRecruitingNCT04361708Phase 1
- A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWTRecruitingNCT04322318Phase 2
- Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsRecruitingNCT04304352Phase 2
- Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)Not yet recruitingNCT04301375Phase 2
- Split-course SBRT for Borderline Resectable and Locally Advanced Pancreatic CancerRecruitingNCT04289792Phase 2
- Chemoradiotherapy in Unresectable Esophageal CancerRecruitingNCT04278287Phase 1/2
- Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Oropharyngeal Cancer.RecruitingNCT04277858Phase 2
- Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/ImmunotherapyRecruitingNCT04253964Phase 2
- High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)RecruitingNCT04221035Phase 3
- Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel CancersRecruitingNCT04205968Phase 2
- Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent SarcomaRecruitingNCT04199026Not applicable
- Treatment of Locally Advanced VULvar CArcinoma in a Neoadjuvant Setting With Carboplatin and Paclitaxel Chemotherapy (VULCANize)RecruitingNCT04192253Phase 2
- Treatment of Metastatic Vulvar Carcinoma With Carboplatin and Paclitaxel ChemotherapyRecruitingNCT04161664Phase 2
- Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast CancerRecruitingNCT04159142Phase 2
- Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast CancerRecruitingNCT04138719Phase 2
- Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCTRecruitingNCT04137653Phase 3
- ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian CancerRecruitingNCT04055649Phase 2
- International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic LymphomaRecruitingNCT04043494Phase 3
- FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing SurgeryRecruitingNCT04016389Not applicable
- Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell LymphomaRecruitingNCT04002947Phase 2
- Neoadjuvant Therapy With Nab-paclitaxel and Cisplatin for Locally Advanced Esophageal Squamous Cell CarcinomaRecruitingNCT03964753Phase 2
- Docetaxel Versus Oxaliplatin as Addition to S-1 for Stage II / III Gastric AdenocarcinomaRecruitingNCT03961867Phase 3
- Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast CancerRecruitingNCT03926091Phase 3
- Cisplatin-based and Carboplatin-based Chemoradiation in Locoregionally Advanced Nasopharyngeal CarcinomaRecruitingNCT03919552Phase 3
- Optimized Treatment Strategies for Early and Medium Stage Nasopharyngeal CarcinomaRecruitingNCT03908372Phase 2/3
- ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate CancerRecruitingNCT03903835Phase 3
- A Study of PET Adapted Therapy and Non-invasive Monitoring for Previously Untreated Limited Stage Diffuse Large B Cell LymphomaRecruitingNCT03758989Phase 2
- A Study of GB201 in Combination With Weekly Paclitaxel and Low-dose Gemcitabine in Patients With Pancreatic CancerRecruitingNCT03721744Phase 2/3
- Capecitabine Versus Vinorelbine in High Risk Breast Cancer With Pathologic Residual Tumors After Preoperative ChemotherapyNot yet recruitingNCT03703427Phase 2
- A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer PatientsRecruitingNCT03671044Phase 3
- PPI Versus Histamine Antagnists as Adjuvant to ChemotherapyRecruitingNCT03647072Phase 3
- Study of Anlotinib Combined With Docetaxel in Non-Driver Mutation Non-squamous NSCLC: the Save StudyRecruitingNCT03646968Phase 2
- Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017RecruitingNCT03643276Phase 3
- Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node SpreadRecruitingNCT03534713Phase 3
- Testing the Combination of Two Approved Chemotherapy Drugs and Radiation Prior to Surgery in Localized Pancreatic CancerRecruitingNCT03492671Phase 2
- A Trial Comparing Adjuvant Chemotherapy With Observation After Concurrent Chemoradiotherapy of Cervical Cancer (With Pelvic or Para-aortic Node Involvement)RecruitingNCT03468010Phase 3
- A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Patients With Metastatic or Locally Advanced Breast CancerRecruitingNCT03424005Phase 1/2
- Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCCRecruitingNCT03326947Phase 2
- Addition of Cisplatin to Adjuvant Chemotherapy for Early Stage Breast Cancer in High-Risk WomenRecruitingNCT03201861Phase 3
- Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)RecruitingNCT03126916Phase 3